Relevance: Prelims: Science
Why in news?
Hyderabad-based Bharat Biotech has partnered with the University of Wisconsin Madison and US-based company FluGen to develop a vaccine, Coro-Flu, against Covid-19.
About:
- CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR. M2SR is a self-limiting version of the influenza virus that induces an immune response against the flu.
- Kawaoka’s lab will insert gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease Covid-19, into M2SR so that the new vaccine will also induce immunity against the coronavirus.
- CoroFlu could be in human clinical trials by the fall of 2020.
For more such notes, Articles, News & Views Join our Telegram Channel.
Click the link below to see the details about the UPSC –Civils courses offered by Triumph IAS. https://triumphias.com/pages-all-courses.php